[go: up one dir, main page]

BRPI0704238A - preventivo da doença de coccidiose e clostrìdica e/ou terapia para a doença de coccidiose e clostridica - Google Patents

preventivo da doença de coccidiose e clostrìdica e/ou terapia para a doença de coccidiose e clostridica

Info

Publication number
BRPI0704238A
BRPI0704238A BRPI0704238-8A BRPI0704238A BRPI0704238A BR PI0704238 A BRPI0704238 A BR PI0704238A BR PI0704238 A BRPI0704238 A BR PI0704238A BR PI0704238 A BRPI0704238 A BR PI0704238A
Authority
BR
Brazil
Prior art keywords
coccidiosis
disease
clostridial
thymol
limonene
Prior art date
Application number
BRPI0704238-8A
Other languages
English (en)
Inventor
Yukihiro Motozono
Hiroyuki Suzuki
Kazuhiro Hatano
Masaaki Kise
Shinichi Horigome
Katsuhiro Mori
Yoshinaga Doi
Ryoji Koga
Original Assignee
Marubeni Nisshin Feed Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Marubeni Nisshin Feed Co Ltd filed Critical Marubeni Nisshin Feed Co Ltd
Publication of BRPI0704238A publication Critical patent/BRPI0704238A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/752—Citrus, e.g. lime, orange or lemon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Fodder In General (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PREVENTIVO DA DOENçA DE COCCIDIOSE E CLOSTRìDICA E/OU TERAPIA PARA A DOENçA DE COCCIDIOSE E CLOSTRìDICA é apresentada uma ração animal, com um agente anti-coccidico, e um agente de anti-clostrídico tendo menos risco e excelente efeito profilático e/ou terapêutico para a doença de coccidiose e clostrídica. Também é apresentada uma ração profilática e/ou terapêutica para a coccidiose contendo pineno, timol, engenol e limoneno; um agente anti-coccidico contendo pineno, timol, eugenol, e limoneno como ingredientes ativos; uma ração profilática e/ou terapêutica para doença clostrídica contendo pineno. timol, eugenol, e limoneno; e um agente anti-clostrídico contendo pineno, timol, eugenol, e limoneno como os ingredientes ativos.
BRPI0704238-8A 2006-10-31 2007-10-30 preventivo da doença de coccidiose e clostrìdica e/ou terapia para a doença de coccidiose e clostridica BRPI0704238A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2006295872A JP5101081B2 (ja) 2006-10-31 2006-10-31 コクシジウム症・クロストリジウム症の予防及び／又は治療用飼料

Publications (1)

Publication Number Publication Date
BRPI0704238A true BRPI0704238A (pt) 2008-06-24

Family

ID=39420888

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0704238-8A BRPI0704238A (pt) 2006-10-31 2007-10-30 preventivo da doença de coccidiose e clostrìdica e/ou terapia para a doença de coccidiose e clostridica

Country Status (4)

Country Link
US (1) US20080160000A1 (pt)
JP (1) JP5101081B2 (pt)
CN (1) CN101171954A (pt)
BR (1) BRPI0704238A (pt)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009074215A1 (en) * 2007-12-11 2009-06-18 Dsm Ip Assets B.V. Use of a composition comprising sesquiterpenes from curcuma essential oil and/or tea tree oil in the manufacture of an animal feed
WO2010060660A1 (en) * 2008-11-27 2010-06-03 Dsm Ip Assets B.V. Use of natural substances as feed additives for animals of the genus equidae
EP2397147B1 (en) 2008-12-12 2015-06-03 Idemitsu Kosan Co., Ltd. Feed for preventing and/or treating diseases caused by clostridium bacterium in livestock, and agent against clostridium
CN104161165B (zh) * 2009-04-09 2016-08-10 马来西亚博特拉大学 单胃动物饲料
CA2767873C (en) * 2009-07-17 2018-08-21 Dsm Ip Assets B.V. Use of natural substances as feed additives for aquatic animals
WO2011036048A1 (en) 2009-09-24 2011-03-31 Unilever Nv Disinfecting agent comprising eugenol, terpineol and thymol
BR112013013085B1 (pt) 2010-12-07 2018-02-14 Unilever N.V. Composição de cuidados orais, enxaguante bucal, creme dental, dentífrico, método para desinfetar a cavidade oral e uso de uma composição
CN102217712A (zh) * 2011-05-27 2011-10-19 贺喜 含蒎烯的饲料或饲料添加剂
KR101350160B1 (ko) * 2011-09-01 2014-01-08 강민기 한약재 추출물을 포함하는 항콕시듐 조성물
KR101339956B1 (ko) 2011-09-01 2013-12-10 주식회사 신일바이오젠 한약재 추출물을 포함하는 항콕시듐 조성물
IN2014MN00808A (pt) 2011-11-03 2015-09-04 Unilever Plc
BR112014021232A2 (pt) * 2012-02-27 2020-11-10 Universidad Peruana Cayetano Heredia composição do óleo essencial da casca do limão como promotor do crescimento na indústria avícola
CN102987093A (zh) * 2012-10-29 2013-03-27 安佑（中国）动物营养研发有限公司 一种饲用植物精油添加剂及其制备方法、用途
GB201404505D0 (en) * 2013-09-06 2014-04-30 Mars Inc Oral anti-parasitic composition
CN103695326A (zh) * 2014-01-03 2014-04-02 湖南大学 一种处理分散式高浓度有机废水的酵母及其制备方法与应用
CN104839081A (zh) * 2014-02-14 2015-08-19 陈洪江 一种草本咖啡猪喂养方法
CN104351563A (zh) * 2014-11-27 2015-02-18 山东新希望六和集团有限公司 一种用于预防猪恶性水肿的功能性饲料及其制备方法
NL2014381B1 (en) 2015-03-02 2016-10-14 Nutreco Nederland Bv Use of a polyphenol for decreasing growth retardation.
CN105475666B (zh) * 2015-12-07 2020-11-03 山川生物科技(武汉)有限公司 一种防治鸡球虫病的饲料添加剂制备方法
US11324236B2 (en) * 2016-02-12 2022-05-10 Idemitsu Kosan Co., Ltd. Functional feed
CN106578386B (zh) * 2016-12-20 2021-01-29 河南科技学院 麝香草酚的新应用
CN107006722A (zh) * 2017-05-05 2017-08-04 广西农业职业技术学院 一种改善鸡肉肉质风味的复方沉香饲料及其制备方法
CN107279535B (zh) * 2017-07-12 2019-01-04 江苏隆达生物科技有限公司 一种用于新生仔猪驱虫的饲料添加剂及生产方法
IT202000009922A1 (it) * 2020-05-05 2021-11-05 Vetagro Int S R L Composizioni comprendenti timolo per uso nel trattamento di disturbi intestinali infiammatori o funzionali mediante modulazione del sistema endocannabinoide
KR102858162B1 (ko) 2020-09-25 2025-09-09 씨제이제일제당 (주) 은행잎을 포함하는 항콕시듐용 조성물 및 이의 용도
KR102660905B1 (ko) * 2020-09-25 2024-04-24 씨제이제일제당 (주) 비올라세인을 포함하는 항콕시듐용 조성물 및 이의 용도
KR102718991B1 (ko) 2020-09-25 2024-10-16 씨제이제일제당 (주) 스틸벤계 화합물을 포함하는 항콕시듐증 조성물 및 이의 용도
KR102755997B1 (ko) 2020-09-25 2025-01-15 씨제이제일제당 (주) 망고스틴을 포함하는 항콕시듐용 조성물 및 이의 용도
KR20220125628A (ko) 2021-03-05 2022-09-14 씨제이제일제당 (주) 쿠마린산을 포함하는 항콕시듐용 조성물 및 이의 용도
CN114514962A (zh) * 2022-02-26 2022-05-20 北京九州大地生物技术集团股份有限公司 一种低毒素禽用饲料及其制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2599161B2 (ja) * 1987-12-26 1997-04-09 日清製粉株式会社 家畜及び家禽のクロストリジウムパーフリンゲンス感染症の予防及び治療剤
JPH0746963A (ja) * 1993-08-06 1995-02-21 Nippon Terupen Kagaku Kk 家畜用飼料
US5976580A (en) * 1995-06-07 1999-11-02 Novus International, Inc. Nutrient formulation and process for enhancing the health, livability, cumulative weight gain or feed efficiency in poultry and other animals
GR1002451B (el) * 1995-06-29 1996-10-14 ������ �. Αντιφλεγμονωδεις συνθεσεις που εχουν ως βαση ενεργα συστατικα ορισμενων βοτανων χρησιμοποιουμενες για σκοπους ιατρικους και κτηνιατρικους, και μεθοδοι παρασκευης φαρμακων και σκευασματων για τους παραπανω σκοπους.
SE511025C2 (sv) * 1997-10-03 1999-07-26 Probi Ab Foderprodukt för häst omfattande Lactobacillus plantarum JI:1 samt Lactobacillus plantarum JI:1 och användning därav
JPH11285378A (ja) * 1997-12-01 1999-10-19 Eisai Co Ltd 抗菌作用を有する新規枯草菌
SE9801742L (sv) * 1998-05-18 1999-11-19 Akzo Nobel Nv Användning av naturliga substanser innehållande tymol vid framställning av djurfoder
JP3338928B2 (ja) * 1998-06-06 2002-10-28 機能研産業株式会社 抗コクシジウム剤
JP4531948B2 (ja) * 2000-04-13 2010-08-25 日清丸紅飼料株式会社 抗コクシジウム剤
CA2455595C (en) * 2001-07-27 2010-06-01 Alltech, Inc. Compositions of yeast cell walls and mannanoligosaccharides for control of coccidiosis
KR100356672B1 (ko) * 2001-12-27 2002-10-19 주식회사 바이로박트 신규한 락토바실러스 속 미생물 및 그 용도
FR2834718B1 (fr) * 2002-01-15 2004-12-24 Cognis France Sa Substances actives cosmetiques et/ou pharmaceutiques
JP2004236552A (ja) * 2003-02-05 2004-08-26 Marubeni Nisshin Feed Co Ltd 反芻動物用発育促進剤
JP4903559B2 (ja) * 2004-03-16 2012-03-28 コンビ株式会社 家畜・家禽類又は魚介類の感染防除剤
US20060159727A1 (en) * 2005-01-20 2006-07-20 Pimentel Julio L Prevention of Systemic Microbial Infection

Also Published As

Publication number Publication date
JP2008110951A (ja) 2008-05-15
US20080160000A1 (en) 2008-07-03
CN101171954A (zh) 2008-05-07
JP5101081B2 (ja) 2012-12-19

Similar Documents

Publication Publication Date Title
BRPI0704238A (pt) preventivo da doença de coccidiose e clostrìdica e/ou terapia para a doença de coccidiose e clostridica
BRPI0925036B8 (pt) uso de trans-t-butil ciclo-hexanol, composição cosmética, medicamento, seus usos e processos para tratar irritação na pele
CR11724A (es) Agente para tratar enfermedades
BR112021011289A2 (pt) Composição farmacêutica para prevenção ou tratamento de câncer compreendendo weissella cibaria wikim28 como ingrediente ativo
BR112018003845A2 (pt) auxiliares cirúrgicos com medicamentos afetados por materiais ativadores
BR112021022789A2 (pt) Métodos, sistemas e dispositivos para a seleção de pacientes para tl1a
BR112015001158A2 (pt) formulação oftálmica e respectivo uso e método para melhorar, reduzir ou tratar presbiopia
BR112015001419A2 (pt) composto, composição farmacêutica, e, métodos para inibir romk em um paciente, para causar diurese, natriurese ou ambos e para tratamento de um ou mais distúrbios
BRPI0819690B8 (pt) uso de uma composição compreendendo cisteamina ou cistamina, ou um sal farmaceuticamente aceitável das mesmas
UY31080A1 (es) Derivados de pirazol sustituidos con heteroarilo utiles para tratar trastornos hiperproliferativos y enfermedades asociadas con angiogénesis
BR112017027811A2 (pt) conjugados específicos de inibidores de ksp
BR112014019262A8 (pt) Composições orais veterinárias parasíticas compreendendo ingredientes ativos de ação sistêmica, métodos e uso das mesmas
BR112012022797A2 (pt) composição farmacêutica resistente a álcool, e, método para tratar uma doença com uma formulação de agente ativo resistente a álcool
BR112012006010A2 (pt) composto de glicina
AR049518A1 (es) Composicion farmaceutica que comprende un agente siliconado y dos principios activos solubilizados
BR112012030641A2 (pt) métodos e composições para terapia farmacêutica oral
BR112017016087A2 (pt) formulações para coxim articular adiposo e métodos de uso das mesmas
MX385860B (es) Peptido para usarse para reducir la necesidad de cirugía en pacientes que tienen hiperplasia prostática beningna.
BR112012024887A2 (pt) grânulos de quitosana, preenchedor, processo para preparar os grânulos de quitosana, kit e disposto de injeção
BR112018076800A2 (pt) derivado de guanidina, medicamento, inibidor da proteína 1 da translocação de linfoma de tecido linfóide associado com mucosa, e, agente terapêutico ou profilático.
MY147864A (en) Beta-2 adrenoceptor agonists for treating connective tissue diseases of the skin
CL2011002160A1 (es) Compuestos derivados de 3-amino-2-mercaptoquinolinas sustituidas; composicion farmaceutica que contiene dichos compuestos; y su uso para tratar dolor, epilepsis, incontinencia urinaria, manias, migraña, trastornos bipolares, enfermedades cognitivas, discinesia asociada a la distonia y/o incontinencia urinaria.
WO2019010301A8 (en) Treatment of heart disease by inhibition of the action of muscle a-kinase anchoring protein (makap)
MX2019015927A (es) Composiciones para administración de fármacos y métodos de uso de las mismas.
BRPI0712561B8 (pt) Uso de 3-oxo-3,4-diidro-2-pirazinacarboxamida

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2278 DE 02/09/2014.

B15K Others concerning applications: alteration of classification

Ipc: A61K 35/747 (2015.01), A61K 31/05 (2006.01), A61K